Introduction
CxBladder is a non-invasive urine test designed to detect bladder cancer by analyzing specific biomarkers in the urine. It is particularly useful for patients with hematuria or those undergoing bladder cancer surveillance. At Crossroads Urology, CxBladder testing provides advanced, accurate diagnostics to guide patient care.
Purpose
CxBladder testing is used to:
- Detect bladder cancer in patients with blood in the urine (hematuria).
- Monitor patients with a history of bladder cancer for recurrence.
- Provide a non-invasive alternative to cystoscopy in select cases.
- Reduce unnecessary invasive testing when the likelihood of cancer is low.
Procedure
- A fresh urine sample is collected in a specialized CxBladder kit provided to the patient.
- The sample is sent to the laboratory, where biomarkers associated with bladder cancer are analyzed.
- Results are typically available within 7-10 days.
Preparation
- Patients should avoid voiding for at least 1-2 hours before the test to ensure a concentrated sample.
- Avoid contamination by following clean-catch instructions provided with the test kit.
Risks and Considerations
- The test is non-invasive and carries no physical risks.
- CxBladder is a supplementary test and may be used alongside imaging or cystoscopy for a comprehensive evaluation.
At Crossroads Urology, we integrate CxBladder testing into a broader diagnostic strategy to ensure accurate and timely diagnosis.
Results
- Results are categorized as low, intermediate, or high risk for bladder cancer.
- High-risk results may require further evaluation, such as cystoscopy or imaging.
Conclusion
Cx Bladder testing offers a reliable, non-invasive method for detecting and monitoring bladder cancer. At Crossroads Urology, we utilize advanced diagnostic tools like CxBladder to deliver exceptional care. Contact us today to learn more about CxBladder testing and schedule your evaluation.
